Article
Author(s):
Newark, NJ-Topical beta-blockers are much safer than physicians believe them to be, according to New Jersey glaucoma specialist Paul Lama, MD.
Myopia onset predicted by accelerated eye changes a year in advance
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Economic burden of late-stage age-related macular degeneration
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Prevent Blindness declares April as Women’s Eye Health and Safety Month
OKYO Pharma releases positive long-term stability data for urcosimod in neuropathic corneal pain